[go: up one dir, main page]

AU2001283267A1 - Genetic loci indicative of propensity for longevity and methods for identifying propensity for age-related disease - Google Patents

Genetic loci indicative of propensity for longevity and methods for identifying propensity for age-related disease

Info

Publication number
AU2001283267A1
AU2001283267A1 AU2001283267A AU8326701A AU2001283267A1 AU 2001283267 A1 AU2001283267 A1 AU 2001283267A1 AU 2001283267 A AU2001283267 A AU 2001283267A AU 8326701 A AU8326701 A AU 8326701A AU 2001283267 A1 AU2001283267 A1 AU 2001283267A1
Authority
AU
Australia
Prior art keywords
propensity
longevity
age
methods
related disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001283267A
Inventor
Louis M. Kunkel
Thomas T. Perls
Annibale Puca
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Childrens Hospital
Beth Israel Deaconess Medical Center Inc
Original Assignee
Boston Childrens Hospital
Beth Israel Deaconess Medical Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Childrens Hospital, Beth Israel Deaconess Medical Center Inc filed Critical Boston Childrens Hospital
Publication of AU2001283267A1 publication Critical patent/AU2001283267A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001283267A 2000-08-11 2001-08-10 Genetic loci indicative of propensity for longevity and methods for identifying propensity for age-related disease Abandoned AU2001283267A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US22464300P 2000-08-11 2000-08-11
US60/224,643 2000-08-11
US24992100P 2000-11-17 2000-11-17
US60/249,921 2000-11-17
PCT/US2001/025099 WO2002014552A2 (en) 2000-08-11 2001-08-10 Genetic loci indicative of propensity for longevity and methods for identifying propensity for age-related disease

Publications (1)

Publication Number Publication Date
AU2001283267A1 true AU2001283267A1 (en) 2002-02-25

Family

ID=26918899

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001283267A Abandoned AU2001283267A1 (en) 2000-08-11 2001-08-10 Genetic loci indicative of propensity for longevity and methods for identifying propensity for age-related disease

Country Status (4)

Country Link
US (2) US6673546B2 (en)
EP (1) EP1317567A2 (en)
AU (1) AU2001283267A1 (en)
WO (1) WO2002014552A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001283267A1 (en) * 2000-08-11 2002-02-25 Beth Israel Deaconess Medical Center Genetic loci indicative of propensity for longevity and methods for identifying propensity for age-related disease
WO2003000861A2 (en) 2001-06-22 2003-01-03 The Regents Of The University Of California Eukaryotic genes involved in adult lifespan regulation
WO2010005303A2 (en) * 2008-07-07 2010-01-14 Publiekrechtelijke Rechtspersoon Academisch Ziekenhuis Leiden H.O.D.N. Leids Universitair Medisch Centrum New indicators of human longevity and biological ageing rate
US20100081916A1 (en) * 2008-09-29 2010-04-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware. Histological facilitation systems and methods
US20100081915A1 (en) * 2008-09-29 2010-04-01 Searete Llc, Alimited Liability Corporation Of The State Of Delaware Histological facilitation systems and methods
US20100081926A1 (en) * 2008-09-29 2010-04-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Histological facilitation systems and methods
US20100081927A1 (en) * 2008-09-29 2010-04-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Histological facilitation systems and methods
US20100081928A1 (en) * 2008-09-29 2010-04-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Histological Facilitation systems and methods
US20100081924A1 (en) * 2008-09-29 2010-04-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Histological facilitation systems and methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999042619A2 (en) * 1998-02-20 1999-08-26 City Of Hope Association of the serotonin transport (htt) gene with cardiovascular disease and longevity
AU2001283267A1 (en) * 2000-08-11 2002-02-25 Beth Israel Deaconess Medical Center Genetic loci indicative of propensity for longevity and methods for identifying propensity for age-related disease

Also Published As

Publication number Publication date
WO2002014552A2 (en) 2002-02-21
WO2002014552A3 (en) 2003-04-10
US20020072063A1 (en) 2002-06-13
EP1317567A2 (en) 2003-06-11
US20040185471A1 (en) 2004-09-23
US6673546B2 (en) 2004-01-06

Similar Documents

Publication Publication Date Title
AU2001234608A1 (en) Methods for analysis of gene expression
AU2002232393A1 (en) Methods for identifying genes associated with diseases or specific phenotypes
AU2001263359A1 (en) Multiplex amplification and analysis of selected str loci
AU2002220920A1 (en) Method for identification of genes involved in specific diseases
AU2002337030A1 (en) Method for analyzing nucleic acid sequences and gene expression
AU2002361908A1 (en) Methods for identifying marker genes for cancer
AU5796099A (en) A new method of identifying non-host plant disease resistance genes
AU2003303395A8 (en) Target-dependent transcription using deletion mutants of n4 rna polymerase
AU2002214126A1 (en) Genetic analysis of microorganisms
AU2001283267A1 (en) Genetic loci indicative of propensity for longevity and methods for identifying propensity for age-related disease
AU5272899A (en) Primer-specific and mispair extension assay for identifying gene variation
AU2001271841A1 (en) Methods for identifying combinations of drugs
AUPQ659800A0 (en) Genetic sequences and uses therefor
AU2001253063A1 (en) Reverse genetic strategy for identifying functional mutations in genes of known sequence
AU5328600A (en) Nucleotide sequences for gene regulation and methods of use thereof
AU2002336999A1 (en) Model of autoimmune disease and methods for identifying agents against autoimmune disease
AU2002222618A1 (en) Method of analyzing gene expression
AU2001270723A1 (en) Method for identifying a functional biological characteristic of a living matter
AUPP727398A0 (en) Methods of identifying antigen gene sequences
AU2928400A (en) Analysis of differential gene expression
AU2002305788A1 (en) Genetic markers for improved disease resistance in animals (nramp1)
AU2001249245A1 (en) Identification of in vivo dna binding loci of chromatin proteins using a tethered nucleotide modification enzyme
AU2001278872A1 (en) Method of identifying a binding partner of a gene product
AU2002358580A1 (en) Methods of identifying genetic risk for and evaluating treatment of alzheimer's disease by determing single nucleotide polymorphisms
IL145055A0 (en) Methods and reagents for identifying synthetic genetic elements